Organigram (OGI) Competitors

Cipher Pharmaceuticals (TSE:CPH) and Organigram (TSE:OGI) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, dividends, media sentiment, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk.

Do institutionals & insiders believe in CPH or OGI?

1.1% of Cipher Pharmaceuticals shares are held by institutional investors. Comparatively, 9.0% of Organigram shares are held by institutional investors. 44.5% of Cipher Pharmaceuticals shares are held by insiders. Comparatively, 27.3% of Organigram shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Do analysts recommend CPH or OGI?

Cipher Pharmaceuticals presently has a consensus price target of C$8.75, indicating a potential downside of 0.79%. Organigram has a consensus price target of C$3.77, indicating a potential upside of 32.63%. Given Cipher Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe Organigram is more favorable than Cipher Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cipher Pharmaceuticals	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Organigram	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Which has more risk and volatility, CPH or OGI?

Cipher Pharmaceuticals has a beta of 1.04, meaning that its stock price is 4% more volatile than the S&P 500. Comparatively, Organigram has a beta of 1.1, meaning that its stock price is 10% more volatile than the S&P 500.

Does the media refer more to CPH or OGI?

In the previous week, Organigram had 10 more articles in the media than Cipher Pharmaceuticals. MarketBeat recorded 15 mentions for Organigram and 5 mentions for Cipher Pharmaceuticals. Organigram's average media sentiment score of 0.30 beat Cipher Pharmaceuticals' score of -0.14 indicating that Cipher Pharmaceuticals is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cipher Pharmaceuticals	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Organigram	2 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Does the MarketBeat Community favor CPH or OGI?

Cipher Pharmaceuticals received 131 more outperform votes than Organigram when rated by MarketBeat users. Likewise, 62.46% of users gave Cipher Pharmaceuticals an outperform vote while only 44.76% of users gave Organigram an outperform vote.

Company	Underperform	Outperform
Cipher Pharmaceuticals	Outperform Votes 178 62.46%	Underperform Votes 107 37.54%
Organigram	Outperform Votes 47 44.76%	Underperform Votes 58 55.24%

Which has better earnings and valuation, CPH or OGI?

Cipher Pharmaceuticals has higher earnings, but lower revenue than Organigram. Organigram is trading at a lower price-to-earnings ratio than Cipher Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cipher Pharmaceuticals	C$21.16M	9.94	C$20.38M	C$1.10	7.93
Organigram	C$149.21M	1.96	-C$229.48M	-C$2.51	-1.13

Is CPH or OGI more profitable?

Cipher Pharmaceuticals has a net margin of 96.32% compared to Cipher Pharmaceuticals' net margin of -153.80%. Organigram's return on equity of 28.19% beat Cipher Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cipher Pharmaceuticals	96.32%	28.19%	8.06%
Organigram	-153.80%	-54.53%	-5.56%

Summary

Cipher Pharmaceuticals beats Organigram on 11 of the 18 factors compared between the two stocks.